Table 6.

Antimicrobial studies performed with CUR in CS.

Type of CS	[CUR] Formulation	Microorganism	Type of Culture	Antimicrobial Method	Antimicrobial [CUR]	Reference
PEG-CS	4.4%, 5 mg/mL	MRSA, P. aeruginosa	Planktonic, Animal model	OD600nm, CFU	5 and 10 mg/mL *	[148]
CCS microspheres	12.27 mg/mL, 1 mol	S. aureus, E. coli	Planktonic	Zone of inhibition, MIC	N/R	[149]
CS nanoparticles	1.06 mg/mL	S. mutans	Planktonic, biofilm	MIC	0.114 mg/mL	[150]
CS-CMS-MMT	0.0004–0.004 g	S. mutans	Planktonic, Biofilm	MIC	0.101 mg/mL	[151]
CS-GP-CUR	148.09 ± 5.01 µg	S. aureus	Planktonic	Zone of inhibition, tissue bacteria count	N/C	[152]
PVA-CS-CUR	N/C	E. coli, P. aeruginosa, S. aureus, B. subtilis	Planktonic	Zone of inhibition	N/R	[153]
PVA-CS-CUR	10, 20, 30 mg	P. multocida, S. aureus, E. coli, B. subtilis	Planktonic	Zone of inhibition	10, 20, 30 mg	[154]
CS NPs	2, 4, 8, 16%	C. albicans, S. aureus	Planktonic, Biofilm	MIC, Colony count	400 mg/mL	[155]
CS NPs	4 mg/mL	HCV-4	N/R	Antiviral assay	15 µg/mL	[156]
CS/milk protein nanocomposites	100 mg	PVY	Plant infection	Antiviral activity	500, 1000, 1500 mg/100 mL	[157]

[CUR]: CUR concentration. N/R: not reported. N/C: not clear. *: formulation concentration.